BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33649537)

  • 1. Premalignant pancreatic cells seed stealth metastasis in distant organs in mice.
    Yamaguchi J; Kokuryo T; Yokoyama Y; Ebata T; Ochiai Y; Nagino M
    Oncogene; 2021 Mar; 40(12):2273-2284. PubMed ID: 33649537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice.
    Liao J; Chung YT; Yang AL; Zhang M; Li H; Zhang W; Yan L; Yang GY
    Mol Carcinog; 2013 Sep; 52(9):739-50. PubMed ID: 22549877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.
    Tiwari A; Tashiro K; Dixit A; Soni A; Vogel K; Hall B; Shafqat I; Slaughter J; Param N; Le A; Saunders E; Paithane U; Garcia G; Campos AR; Zettervall J; Carlson M; Starr TK; Marahrens Y; Deshpande AJ; Commisso C; Provenzano PP; Bagchi A
    Gastroenterology; 2020 Nov; 159(5):1882-1897.e5. PubMed ID: 32768595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of thymic tumor in [LSL:Kras
    Liot S; El Kholti N; Balas J; Genestier L; Verrier B; Valcourt U; Lambert E
    Sci Rep; 2021 Jul; 11(1):15075. PubMed ID: 34302028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing aldo-keto reductase family 1B10 (AKR1B10).
    Li H; Yang AL; Chung YT; Zhang W; Liao J; Yang GY
    Carcinogenesis; 2013 Sep; 34(9):2090-8. PubMed ID: 23689354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
    Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
    Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer.
    Zhong Y; Macgregor-Das A; Saunders T; Whittle MC; Makohon-Moore A; Kohutek ZA; Poling J; Herbst BT; Javier BM; Cope L; Leach SD; Hingorani SR; Iacobuzio-Donahue CA
    Clin Cancer Res; 2017 Mar; 23(6):1607-1620. PubMed ID: 27637888
    [No Abstract]   [Full Text] [Related]  

  • 8. Proteasome activity is required for the initiation of precancerous pancreatic lesions.
    Furuyama T; Tanaka S; Shimada S; Akiyama Y; Matsumura S; Mitsunori Y; Aihara A; Ban D; Ochiai T; Kudo A; Fukamachi H; Arii S; Kawaguchi Y; Tanabe M
    Sci Rep; 2016 May; 6():27044. PubMed ID: 27244456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas.
    Ischenko I; Petrenko O; Hayman MJ
    Proc Natl Acad Sci U S A; 2014 Mar; 111(9):3466-71. PubMed ID: 24550494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer.
    Morton JP; Timpson P; Karim SA; Ridgway RA; Athineos D; Doyle B; Jamieson NB; Oien KA; Lowy AM; Brunton VG; Frame MC; Evans TR; Sansom OJ
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):246-51. PubMed ID: 20018721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose metabolism during tumorigenesis in the genetic mouse model of pancreatic cancer.
    Pasquale V; Dugnani E; Liberati D; Marra P; Citro A; Canu T; Policardi M; Valla L; Esposito A; Piemonti L
    Acta Diabetol; 2019 Sep; 56(9):1013-1022. PubMed ID: 30989379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Chronic Pancreatitis and Murine Pancreatic Intraepithelial Neoplasia by a Dual Inhibitor of c-RAF and Soluble Epoxide Hydrolase in LSL-KrasG¹²D/Pdx-1-Cre Mice.
    Liao J; Hwang SH; Li H; Liu JY; Hammock BD; Yang GY
    Anticancer Res; 2016 Jan; 36(1):27-37. PubMed ID: 26722025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The conditional expression of KRAS G12D in mouse pancreas induces disorganization of endocrine islets prior the onset of ductal pre-cancerous lesions.
    Gout J; Pommier RM; Vincent DF; Ripoche D; Goddard-Léon S; Colombe A; Treilleux I; Valcourt U; Tomasini R; Dufresne M; Bertolino P; Bartholin L
    Pancreatology; 2013; 13(3):191-5. PubMed ID: 23719586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo.
    Qiu W; Sahin F; Iacobuzio-Donahue CA; Garcia-Carracedo D; Wang WM; Kuo CY; Chen D; Arking DE; Lowy AM; Hruban RH; Remotti HE; Su GH
    Oncotarget; 2011 Nov; 2(11):862-73. PubMed ID: 22113502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
    Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
    Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia (PanIN) by capsaicin in LSL-KrasG12D/Pdx1-Cre mice.
    Bai H; Li H; Zhang W; Matkowskyj KA; Liao J; Srivastava SK; Yang GY
    Carcinogenesis; 2011 Nov; 32(11):1689-96. PubMed ID: 21859833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calorie restriction delays the progression of lesions to pancreatic cancer in the LSL-KrasG12D; Pdx-1/Cre mouse model of pancreatic cancer.
    Lanza-Jacoby S; Yan G; Radice G; LePhong C; Baliff J; Hess R
    Exp Biol Med (Maywood); 2013 Jul; 238(7):787-97. PubMed ID: 23828595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.
    Taki K; Ohmuraya M; Tanji E; Komatsu H; Hashimoto D; Semba K; Araki K; Kawaguchi Y; Baba H; Furukawa T
    Oncogene; 2016 May; 35(18):2407-12. PubMed ID: 26257060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis.
    Nishikawa Y; Kodama Y; Shiokawa M; Matsumori T; Marui S; Kuriyama K; Kuwada T; Sogabe Y; Kakiuchi N; Tomono T; Mima A; Morita T; Ueda T; Tsuda M; Yamauchi Y; Sakuma Y; Ota Y; Maruno T; Uza N; Uesugi M; Kageyama R; Chiba T; Seno H
    Oncogene; 2019 May; 38(22):4283-4296. PubMed ID: 30705405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.